{"id":2833,"date":"2021-11-30T10:10:22","date_gmt":"2021-11-30T09:10:22","guid":{"rendered":"https:\/\/wp.idlbiotech.com\/?page_id=2833"},"modified":"2025-06-18T10:52:51","modified_gmt":"2025-06-18T08:52:51","slug":"aktieemissioner-och-foretagstransaktioner","status":"publish","type":"page","link":"https:\/\/idldiagnostics.com\/sv\/investerare\/aktieemissioner-och-foretagstransaktioner\/","title":{"rendered":"Aktieemissioner och f\u00f6retagstransaktioner"},"content":{"rendered":"

[et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”88f366a5-bf49-48d9-a338-ab22706b73e7″ global_colors_info=”{}”][et_pb_row column_structure=”2_3,1_3″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”0px||0px|||” global_colors_info=”{}”][et_pb_column type=”2_3″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”||||false|false” custom_padding_tablet=”10px||||false|false” custom_padding_phone=”0px||||false|false” custom_padding_last_edited=”on|phone” global_colors_info=”{}”][dipi_breadcrumbs _builder_version=”4.16″ _module_preset=”default” global_module=”5324″ global_colors_info=”{}”][\/dipi_breadcrumbs][et_pb_divider color=”#EEEEEE” _builder_version=”4.16″ _module_preset=”default” min_height=”1px” height=”20px” custom_margin=”||3px|||” global_colors_info=”{}”][\/et_pb_divider][et_pb_text _builder_version=”4.27.4″ _module_preset=”8738c908-7375-4c6c-99a7-9f91f8a3c099″ header_font_size=”56px” custom_margin=”||17px|||” global_colors_info=”{}”]<\/p>\n

Aktieemissioner och f\u00f6retagstransaktioner<\/h6>\n

Aktieemissioner och f\u00f6retagstransaktioner<\/h1>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”50px||||false|false” custom_padding_tablet=”10px||||false|false” custom_padding_phone=”0px||||false|false” custom_padding_last_edited=”on|tablet” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” _builder_version=”4.18.0″ _module_preset=”e9afc0e7-c9bf-4a12-be49-63ddba231101″ custom_padding_tablet=”||0px||false|false” custom_padding_phone=”” saved_tabs=”all” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ module_id=”aktieemissioner” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” min_height=”84px” global_colors_info=”{}”]<\/p>\n

Aktieemissioner<\/h3>\n

[\/et_pb_text][et_pb_accordion toggle_icon=”3||divi||400″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_accordion_item title=”R\u00f6r ej” open=”on” _builder_version=”4.17.4″ _module_preset=”default” custom_css_main_element=”Display:none;” global_colors_info=”{}”][\/et_pb_accordion_item][et_pb_accordion_item title=”Ny aktieemission 2022″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Documents are in Swedish.<\/h5>\n

Press release Decision on new share issue<\/a><\/p>\n

Press release Notice of extraordinary general meeting of AroCell AB<\/a><\/p>\n

Prospectus<\/a><\/p>\n

AroCell \u2013 Annual Report 2020<\/a><\/p>\n

AroCell \u2013 Annual Report 2019<\/a><\/p>\n

AroCell \u2013 Q3 2021<\/a><\/p>\n

IDL Biotech \u2013 Annual Report 2020<\/a><\/p>\n

IDL Biotech \u2013 Annual Report 2019<\/a><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Ny aktieemission 2021″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Documents are in Swedish.<\/h5>\n

Prospectus<\/a><\/p>\n

Registration<\/a><\/p>\n

Interim report 1 January \u2013 31 March 2021<\/a><\/p>\n

Annual Report 2020<\/a><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Ny aktieemission 2019″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

<\/h5>\n
Documents are in Swedish.<\/h5>\n

Prospectus 2019<\/a><\/p>\n

The board\u2019s statement of significant events<\/a><\/p>\n

Auditor\u2019s opinion on the board\u2019s statement of significant events<\/a><\/p>\n

The Board of Directors\u2019 decision on rights issue<\/a><\/p>\n

The Board of Directors\u2019 decision on a directed issue<\/a><\/p>\n

Press release Decision on new share issue<\/a><\/p>\n

Press release notice of additional General Meeting<\/a><\/p>\n

Registration Certificate<\/a><\/p>\n

Articles of association<\/a><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Ny aktieemission 2018″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Prospekt<\/a><\/p>\n

Till\u00e4ggsprospekt l<\/a><\/p>\n

Till\u00e4ggsprospekt ll<\/a><\/p>\n

2018-05-22 Sista dag f\u00f6r handel med BTA<\/a><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Notering p\u00e5 First North 2016 ” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Listing At First North 2016 (Pdf)<\/a><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Ny aktieemission 2015″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Prospekt<\/a><\/p>\n

 <\/p>\n

[\/et_pb_accordion_item][\/et_pb_accordion][\/et_pb_column][et_pb_column type=”1_2″ module_id=”foretagstransaktioner” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

F\u00f6retagstransaktioner<\/h3>\n
Fusioner och f\u00f6rv\u00e4rv<\/h5>\n

[\/et_pb_text][et_pb_accordion toggle_icon=”3||divi||400″ _builder_version=”4.27.4″ _module_preset=”default” min_height=”68px” global_colors_info=”{}”][et_pb_accordion_item open=”on” _builder_version=”4.18.0″ _module_preset=”default” custom_css_main_element=”Display:none;” global_colors_info=”{}”][\/et_pb_accordion_item][et_pb_accordion_item title=”Takeover offer of IDL Biotech AB” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Documents are in Swedish.<\/h5>\n

10 maj 2021 \u2013 AroCell AB (publ) l\u00e4mnar ett offentligt uppk\u00f6pserbjudande till aktie\u00e4garna i IDL Biotech AB (publ)<\/a><\/p>\n

8 juni 2021 \u2013 AroCell AB (publ) offentligg\u00f6r erbjudandehandling avseende erbjudandet till aktie\u00e4garna i IDL Biotech AB<\/a><\/p>\n

1 juli 2021 \u2013 AroCell AB (publ) f\u00f6rklarar erbjudandet till <\/a>aktie\u00e4garna i IDL Biotech AB ovillkorat och fullf\u00f6ljer erbjudandet\u00a0<\/a><\/p>\n

1 augusti 2021 \u2013 AroCell AB (publ) offentligg\u00f6r slutligt utfall i erbjudandet till aktie\u00e4garna i IDL Biotech AB<\/a><\/p>\n

[\/et_pb_accordion_item][\/et_pb_accordion][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_module=”3464″ saved_tabs=”all” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_menu menu_id=”47″ disabled_on=”on|on|off” _builder_version=”4.18.0″ _module_preset=”default” background_color=”#F8F8F8″ global_colors_info=”{}”][\/et_pb_menu][et_pb_sidebar area=”et_pb_widget_area_6″ disabled_on=”off|off|on” _builder_version=”4.17.4″ _module_preset=”2efbbc8f-7ecb-4fe3-9956-d83a8a0e7a74″ background_color=”#F8F8F8″ global_colors_info=”{}”][\/et_pb_sidebar][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” _builder_version=”4.9.4″ _module_preset=”default” custom_margin_tablet=”||||false|false” custom_margin_phone=”” custom_margin_last_edited=”on|tablet” custom_padding_tablet=”||0px||false|false” custom_padding_phone=”” global_module=”2177″ saved_tabs=”all” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ make_equal=”on” _builder_version=”4.27.4″ _module_preset=”default” width=”90%” max_width=”2000px” global_colors_info=”{}”][et_pb_column type=”1_2″ module_class=”ds-vertical-align” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Om oss<\/h6>\n

Vi bist\u00e5r med kunskap till beslutsfattare<\/h3>\n

IDL Diagnostics \u00e4r ett svenskt diagnostikf\u00f6retag med visionen att f\u00f6rb\u00e4ttra \u00f6vervakningen av onkologiska och bakteriella sjukdomar. Vi har ett brett produktutbud av IVD-tester som levererar v\u00e4rdefull klinisk information f\u00f6r uppt\u00e4ckt av sjukdomar.<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/idldiagnostics.com\/sv\/om-arocell\/” button_text=”L\u00e4s mer om oss” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/idldiagnostics.com\/sv\/wp-content\/uploads\/2022\/10\/MG_7941-800.jpg” title_text=”MG_7941-600″ src_tablet=”” src_phone=”https:\/\/idldiagnostics.com\/sv\/wp-content\/uploads\/2023\/08\/MG_7941-600.jpg” src_last_edited=”on|phone” _builder_version=”4.22.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\t
\n